Organogenesis Holdings Inc Class A (ORGO) returns

NASDAQ · Health Care

$0.77 -6.20% Close Oct 30, 2026 Live

Organogenesis returns over 5 years

$1,000 invested in Organogenesis five years ago was worth $69.95 at the close on October 30, 2026, with dividends reinvested: an average return of -41.3% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.

ORGO, $10,000 investedS&P 500 (SPY)
$1,000$10,000
20182020202220242026

Total return by period

With dividends reinvested, to the close on Oct 30, 2026. A year means 365 days.
PeriodTotal returnA year, on average$1,000 becameS&P 500 (SPY)
1 month -43.9% — $560.66 -0.9%
3 months -68.6% — $313.51 +2.1%
Year to date -85.2% — $148.28 +11.7%
1 year -81.8% — $181.58 +12.4%
3 years -65.2% -29.7% $347.56 +88.5%
5 years -93.0% -41.3% $69.95 +76.0%

Organogenesis return by calendar year

YearORGOS&P 500 (SPY)Difference
2026 to date -85.2% +11.7% -96.9%
2025 +61.9% +17.7% +44.2%
2024 -21.8% +24.9% -46.6%
2023 +52.0% +26.2% +25.9%
2022 -70.9% -18.2% -52.7%
2021 +22.7% +28.7% -6.0%
2020 +56.5% +18.4% +38.2%
2019 -52.6% +31.2% -83.8%
2018 +2.3% -4.6% +6.9%

Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.

See also: ORGO financials · ORGO valuation

No forecast, no recommendation. This page describes Organogenesis Holdings Inc Class A from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.